Add time:08/16/2019         Source:sciencedirect.com

α7 nicotinic acetylcholine receptor agonists are promising therapeutic candidates for the treatment of cognitive impairment. As a follow up of our internal medicinal chemistry program we investigated a novel series of α7 nAChR agonists. Starting from molecular docking studies on two series of molecules recently developed in our laboratories, an alternative scaffold was designed attempting to combine the optimal features of these previously identified urea and pyrazole compounds. Based on our previous SAR knowledge and on predicted drug-like properties, a small library was synthesized in parallel manner, affording compounds with excellent α7 nAChR activity, selectivity and preliminary ADME profile.

We also recommend Trading Suppliers and Manufacturers of ACETYLCHOLINE-(METHYL-14C) CHLORIDE (cas 16597-28-7). Pls Click Website Link as below: cas 16597-28-7 suppliers